HOME >> MEDICINE >> NEWS
Study finds Velcade major improvement over standard therapy for relapsed multiple myeloma patients

NEW ORLEANSEarly results from a major, international Phase III clinical trial decisively show that recurrent multiple myeloma is more effectively treated with the drug bortezomib (trade name: Velcade TM) than with dexamethasone, a drug that for decades has been the standard therapy for relapsed disease, researchers at Dana-Farber Cancer Institute report.

The findings, which will be presented at the annual meeting of the American Society of Clinical Oncology (Sunday, June 6, 2 p.m. Room 283) were sufficiently striking that the trial was stopped early so that patients who had been randomly assigned to receive dexamethasone could switch to bortezomib.

The study, which involved 669 patients in 92 treatment centers around the world, was the first head-to-head comparison of bortezomib and dexamethasone in a Phase III trial of patients who had relapsed after treatment for multiple myeloma. (Phase III trials test new treatments against standard ones to determine which is safer and more effective.)

"This trial represents the largest, most broad-based assessment to date of bortezomib and dexamethasone in this group of patients," says the study's lead author, Paul Richardson, MD, of Dana-Farber. "The finding that bortezomib significantly lengthened the time to disease progression and improved survival when compared with dexamethasone, with a similar level of safety, is important confirmatory evidence of bortezomib's effectiveness for patients with relapsed multiple myeloma."

Multiple myeloma is a currently incurable cancer of the bone marrow that causes a plunge in the production of vital red and white blood cells. Although relatively rare, it is the second most common type of blood cancer and accounts for 11,000 deaths annually in the United States. It is the fourth fastest-growing cancer in terms of mortality and is among the top 10 causes of death among African Americans.

In the new stud
'"/>

Contact: Bill Schaller
janet_haley@dfci.harvard.edu
617-233-5507
Dana-Farber Cancer Institute
5-Jun-2004


Page: 1 2 3

Related medicine news :

1. Study of energy and health in Africa focuses spotlight on charcoal and forest management
2. Study shows promise in identifying kidney failure
3. Study shows patch therapy may be as effective as oral medications
4. Study shows soy is well accepted in school lunches
5. Study finds that coordinating care of chronically ill patients does not increase liability
6. Study provides new estimates of the causes of child mortality worldwide
7. Study finds factors linked to substance use disorder relapse among health care professionals
8. Study finds majority of women willing to accept cervical cancer vaccine for self and children
9. Study shows use of budesonide reduced the risk of asthma related events by 40% in children
10. Study shows risk of cardiac death after radiation for breast cancer has dramatically decreased
11. Study shows acrylamide in baked and fried food does not increase risk of breast cancer in women

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/28/2020)... ... May 28, 2020 , ... Officials with ... clinically integrated network (CIN) and the group purchasing organization run by Allegheny Health ... establish a heart failure program at Mon Health Medical Center. ...
(Date:5/27/2020)... ... May 27, 2020 , ... The podiatrists and foot doctors ... Michigan, Fowlerville Michigan , and Ann Arbor Michigan. Dr. Tomasz Biernacki ... within the clinic and at the hospital. We have been seeing patients in the ...
(Date:5/26/2020)... ... May 26, 2020 , ... Loyale ... patient messaging and IVR Advantage™--for Loyale customers. Talksoft pre-service messaging solutions complement ... texts, IVR reminders and email messages tailored to each stage of their ...
(Date:5/25/2020)... ... May 23, 2020 , ... Winemaker Grant Long Jr. is introducing three Toilet ... whimsical and delicious in these complicated times,” he said, in announcing the new wines. ... ($24.99). The Chardonnay and Red Wine Blend are sourced in the Napa Valley; the ...
(Date:5/21/2020)... Pa. (PRWEB) , ... May 21, 2020 , ... ... Inc. and an industry leader in cancer biomarker assays, announced today that Cigna ... list. Cigna Corporation is a global health service company dedicated to improving the ...
Breaking Medicine News(10 mins):
(Date:6/2/2020)... ... June 02, 2020 , ... As the leading human capital ... COVID-19 it is working with its corporate team, its consultants, and its healthcare ... host of digital resources. Harmony’s leadership team recognized the extraordinary efforts of the ...
(Date:6/2/2020)... ... June 02, 2020 , ... SCFHP members who call SCFHP’s 24/7 ... and, depending on the inquiry, can now virtually consult with an available physician. Once ... their primary care doctor to ensure seamless care. The nurse advice line with the ...
(Date:5/30/2020)... DALLAS (PRWEB) , ... May 29, 2020 , ... ... launched a unique return-to-work mobile and web based solution People1 Care ... People1 Care helps companies transition into the 'new normal’ through daily wellness screenings, ...
Breaking Medicine Technology:
Cached News: